Accelerate your molecule from discovery to market
Oct 8-10 ,2024
Fiera Milano, ItalyMeet us at Booth #7B82
The Aurigene expertise
Aurigene Pharmaceutical Services Limited is an integrated partner for global pharma companies. It covers the entire value chain for new therapeutics, from drug discovery, clinical research, and development to manufacturing APIs and formulation at commercial scales. It has development laboratories from discovery to clinical phase III for New Chemical and Biological Entities (NCEs/NBEs) and cGMP manufacturing facilities in the UK, Mexico, USA and India. The technology platforms include cytotoxic APIs, carbohydrates, steroids, PEG derivatives, prostaglandins, peptides and oligonucleotides. Large molecule discovery services include ADC, mAb, mRNA, CART-T as well as development services in mAb and protein therapeutics.
About CPHI Milan 2024
CPHI Milan is a premier event in the pharmaceutical industry, bringing together 62,000 professionals from more than 166 countries. The event covers all aspects of pharmaceutical development, including API development, biopharmaceuticals, packaging innovations, and next-gen bio-manufacturing.
With 2,400 exhibitors, and 150 top international speakers, CPHI Milan facilitates connections and idea-sharing among industry leaders, researchers, and business executives.
A key feature of the event is its focus on collaborative learning and innovative solutions, offering attendees the chance to explore the latest advancements in pharmaceuticals, such as new technologies, automation and digitalization in manufacturing, and strategies for improving process efficiency and product quality.
CPHI Milan 2024 is an ideal platform for professionals to stay at the forefront of pharmaceutical development, connect with industry leaders, and explore opportunities for collaboration and growth.
Meet our Experts
We are excited to meet you and explore potential opportunities for collaboration and partnership. To schedule a meeting with us, simply provide us with your information and we will be in touch to arrange a time that works for you. We are excited to connect with you and explore how we can work together to drive success in the industry.
Akhil Ravi
Chief Executive Officer
Kapil Choudhury
Global Head - Business Development
Srividya Ramakrishnan
Global Head - CDMO
Roger Lias
Global Commercial Head - NBE
Rajgopal Sharma
Director- Business Development
Ashwini Kapoor
Director - Business Development
Services we Offer
Chemical Development Services
Aurigene Pharmaceutical Services provides a wide range of pharmaceutical drug development services for pre-clinical and clinical trials I, II and III wherein we synthesize New Chemical Entity (NCE) from few grams for efficacy and toxicology studies to multi-kilogram for clinical trial studies. These can be offered from GLP-compliant and cGMP environment to meet client requirements.
Formulation Development Services
Aurigene Pharmaceutical Services offers end-to-end formulation development services ranging from early development to clinical supplies for new chemical entities for the pharmaceutical, nutraceutical & animal healthcare industry along with life cycle extension of the products. We have the expertise along with the state-of-the-art infrastructure and diverse experience to develop formulations for your pre-clinical and clinical needs to support oral, topical & parenteral administration. Our formulation development effort revolves around developing the best formulation for your compound, focusing on the desired bioavailability and optimal stability of your drug product.Starting with comprehensive pre-formulation services Aurigene Pharmaceutical Services helps its clients to determine optimal dosage forms they can use for pre-clinical or clinical applications.
Manufacturing Services
Aurigene has access to the manufacturing facilities of Dr. Reddy’s and a network of strategic business partners. Our pharmaceutical drug manufacturing services offer a wide range of manufacturing services from a few kilos to multi tons of cGMP manufacturing of Key Starting Material (KSM) / Registered Starting Materials (RSM), advanced intermediates, APIs and finished formulations. We have manufacturing options across the globe, with our facilities located in India, the UK, Mexico and the US. With a strong legacy of supporting New Chemical Entity (NCE) manufacturing, drug substances and drug products commercial manufacturing, we are able to cater to Pharma, Specialty, Nutraceutical and Animal Health companies
Why Aurigene Pharmaceutical Services?
Years of
Expertise
- 400+ projects from more than 100 global customers
- 15+ products in commercial phase
- 700+ dedicated scientists
USFDA inspected
GMP sites
- 4100+ KL capacity
- Reactor volume from 60L to 10KL
- Cryogenic reaction, High Potent and High-pressure reaction capabilities
- Unit operations like: SD, Hydrogenation, ATFD
- Dedicated production blocks for peptides, steroids, and PEG alcohol & PEG derivatives
R&D
Centres
- 10-acre dedicated R&D campus
- 210,000 sq. ft lab space
- 15+ dedicated labs for chemistry, biology and formulation along with analytical center of excellence
CPHI MILAN
Meet us at Booth #7B82
Oct 8-10 ,2024Fiera Milano, ItalyYou are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market